Bioenergetic consequences of PINK1 mutations in Parkinson disease.

<h4>Background</h4>Mutations of the gene for PTEN-induced kinase 1 (PINK1) are a cause of familial Parkinson's disease (PD). PINK1 protein has been localised to mitochondria and PINK1 gene knockout models exhibit abnormal mitochondrial function. The purpose of this study was to dete...

Full description

Saved in:
Bibliographic Details
Main Authors: Andrey Yurevich Abramov, Matthew Gegg, Anne Grunewald, Nicholas William Wood, Christine Klein, Anthony Henry Vernon Schapira
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0025622&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850137024862879744
author Andrey Yurevich Abramov
Matthew Gegg
Anne Grunewald
Nicholas William Wood
Christine Klein
Anthony Henry Vernon Schapira
author_facet Andrey Yurevich Abramov
Matthew Gegg
Anne Grunewald
Nicholas William Wood
Christine Klein
Anthony Henry Vernon Schapira
author_sort Andrey Yurevich Abramov
collection DOAJ
description <h4>Background</h4>Mutations of the gene for PTEN-induced kinase 1 (PINK1) are a cause of familial Parkinson's disease (PD). PINK1 protein has been localised to mitochondria and PINK1 gene knockout models exhibit abnormal mitochondrial function. The purpose of this study was to determine whether cells derived from PD patients with a range of PINK1 mutations demonstrate similar defects of mitochondrial function, whether the nature and severity of the abnormalities vary between mutations and correlate with clinical features.<h4>Methodology</h4>We investigated mitochondrial bioenergetics in live fibroblasts from PINK1 mutation patients using single cell techniques. We found that fibroblasts from PINK1 mutation patients had significant defects of bioenergetics including reduced mitochondrial membrane potential, altered redox state, a respiratory deficiency that was determined by substrate availability, and enhanced sensitivity to calcium stimulation and associated mitochondrial permeability pore opening. There was an increase in the basal rate of free radical production in the mutant cells. The pattern and severity of abnormality varied between different mutations, and the less severe defects in these cells were associated with later age of onset of PD.<h4>Conclusions</h4>The results provide insight into the molecular pathology of PINK1 mutations in PD and also confirm the critical role of substrate availability in determining the biochemical phenotype--thereby offering the potential for novel therapeutic strategies to circumvent these abnormalities.
format Article
id doaj-art-d2ef9e2000334eceb8d03af49fc876d3
institution OA Journals
issn 1932-6203
language English
publishDate 2011-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-d2ef9e2000334eceb8d03af49fc876d32025-08-20T02:30:58ZengPublic Library of Science (PLoS)PLoS ONE1932-62032011-01-01610e2562210.1371/journal.pone.0025622Bioenergetic consequences of PINK1 mutations in Parkinson disease.Andrey Yurevich AbramovMatthew GeggAnne GrunewaldNicholas William WoodChristine KleinAnthony Henry Vernon Schapira<h4>Background</h4>Mutations of the gene for PTEN-induced kinase 1 (PINK1) are a cause of familial Parkinson's disease (PD). PINK1 protein has been localised to mitochondria and PINK1 gene knockout models exhibit abnormal mitochondrial function. The purpose of this study was to determine whether cells derived from PD patients with a range of PINK1 mutations demonstrate similar defects of mitochondrial function, whether the nature and severity of the abnormalities vary between mutations and correlate with clinical features.<h4>Methodology</h4>We investigated mitochondrial bioenergetics in live fibroblasts from PINK1 mutation patients using single cell techniques. We found that fibroblasts from PINK1 mutation patients had significant defects of bioenergetics including reduced mitochondrial membrane potential, altered redox state, a respiratory deficiency that was determined by substrate availability, and enhanced sensitivity to calcium stimulation and associated mitochondrial permeability pore opening. There was an increase in the basal rate of free radical production in the mutant cells. The pattern and severity of abnormality varied between different mutations, and the less severe defects in these cells were associated with later age of onset of PD.<h4>Conclusions</h4>The results provide insight into the molecular pathology of PINK1 mutations in PD and also confirm the critical role of substrate availability in determining the biochemical phenotype--thereby offering the potential for novel therapeutic strategies to circumvent these abnormalities.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0025622&type=printable
spellingShingle Andrey Yurevich Abramov
Matthew Gegg
Anne Grunewald
Nicholas William Wood
Christine Klein
Anthony Henry Vernon Schapira
Bioenergetic consequences of PINK1 mutations in Parkinson disease.
PLoS ONE
title Bioenergetic consequences of PINK1 mutations in Parkinson disease.
title_full Bioenergetic consequences of PINK1 mutations in Parkinson disease.
title_fullStr Bioenergetic consequences of PINK1 mutations in Parkinson disease.
title_full_unstemmed Bioenergetic consequences of PINK1 mutations in Parkinson disease.
title_short Bioenergetic consequences of PINK1 mutations in Parkinson disease.
title_sort bioenergetic consequences of pink1 mutations in parkinson disease
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0025622&type=printable
work_keys_str_mv AT andreyyurevichabramov bioenergeticconsequencesofpink1mutationsinparkinsondisease
AT matthewgegg bioenergeticconsequencesofpink1mutationsinparkinsondisease
AT annegrunewald bioenergeticconsequencesofpink1mutationsinparkinsondisease
AT nicholaswilliamwood bioenergeticconsequencesofpink1mutationsinparkinsondisease
AT christineklein bioenergeticconsequencesofpink1mutationsinparkinsondisease
AT anthonyhenryvernonschapira bioenergeticconsequencesofpink1mutationsinparkinsondisease